Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIV-1 Gag/Pol/Env/Nef represents a composite set of the primary structural, enzymatic, and regulatory proteins of the Human Immunodeficiency Virus type 1. Gag provides the structural framework for the virus, including the capsid and matrix, while Pol encodes essential enzymes such as reverse transcriptase, protease, and integrase. Env consists of the surface glycoproteins gp120 and gp41, which are critical for viral attachment and entry into CD4+ T-cells. Nef is an accessory protein that enhances viral replication and promotes immune evasion by downregulating MHC-I and CD4 molecules on the host cell surface. In therapeutic development, this combination is typically used as an antigenic payload in DNA vaccines or viral vectors to stimulate a broad-spectrum immune response. The goal of targeting these proteins collectively is to induce potent CD8+ cytotoxic T-lymphocyte and CD4+ helper T-cell responses capable of controlling viral replication. This multi-antigen approach is designed to minimize the risk of viral escape mutations, which frequently occur when targeting single epitopes.
Induction of host-mediated cellular and humoral immune responses against multiple HIV-1 viral components to suppress viral replication and eliminate infected cells.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human immunodeficiency virus type 1 Gag-Pol-Env-Nef polyprotein complex (HIV-1 Gag/Pol/Env/Nef).